BridgeMD
Prevention study for Diabetes Mellitus Foot Ulcer
Official title Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)
ClinicalTrials.gov ID: NCT07021222
What this study is testing
- What it's testing
- This is a no-profit, multicentre, national, clinical trial for the prevention of the complications of the diabetic foot in two populations of patients with diabetes mellitus type-2.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- for population 1:
- Male and female patients aged between 18 and 75 years.
- Diabetes mellitus type-2 patients with mild to moderate risk of ulceration at the foot (grade 2). for population 2:
- Male and female patients aged between 18 and 75 years.
- Patients with diabetes mellitus type-2 and diabetic foot with an history of ulcerative lesions (grade 3), healed for at least 6 months.
You likely can't join if
- for population 1:
- History or evidence of ulcers at the foot
- Infections in progress, ongoing neoplasms
- Immunosuppressive therapies, and cortisone-based therapy
- Pregnancy and lactation
- Inability to provide informed consent Exclusion Criteria for population 2:
See the full eligibility criteria
- for population 1:
- Male and female patients aged between 18 and 75 years.
- Diabetes mellitus type-2 patients with mild to moderate risk of ulceration at the foot (grade 2). for population 2:
- Male and female patients aged between 18 and 75 years.
- Patients with diabetes mellitus type-2 and diabetic foot with an history of ulcerative lesions (grade 3), healed for at least 6 months.
- for population 1:
- History or evidence of ulcers at the foot
- Infections in progress, ongoing neoplasms
- Immunosuppressive therapies, and cortisone-based therapy
- Pregnancy and lactation
- Inability to provide informed consent Exclusion Criteria for population 2:
- Infections in progress, ongoing neoplasms
- Immunosuppressive therapies, and cortisone-based therapy
- Pregnancy and lactation
- Inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Bologna, BO, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bologna, BO, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.